Τίτλος:
Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018
Συγγραφείς:
Seys, S.F.
Quirce, S.
Agache, I.
Akdis, C.A.
Alvaro-Lozano, M.
Antolín-Amérigo, D.
Bjermer, L.
Bobolea, I.
Bonini, M.
Bossios, A.
Brinkman, P.
Bush, A.
Calderon, M.
Canonica, W.
Chanez, P.
Couto, M.
Davila, I.
Del Giacco, S.
Del Pozo, V.
Erjefält, J.S.
Gevaert, P.
Hagedoorn, P.
G. Heaney, L.
Heffler, E.
Hellings, P.W.
Jutel, M.
Kalayci, O.
Kurowski, M.M.
Loukides, S.
Nair, P.
Palomares, O.
Polverino, E.
Sanchez-Garcia, S.
Sastre, J.
Schwarze, J.
Spanevello, A.
Ulrik, C.S.
Usmani, O.
Van den Berge, M.
Vasakova, M.
Vijverberg, S.
Diamant, Z.
Λέξεις-κλειδιά:
corticosteroid; dupilumab; immunoglobulin E; interleukin 13; interleukin 4; interleukin 5; irritant agent; mepolizumab; microRNA; omalizumab, asthma; bronchiectasis; chronic obstructive lung disease; chronic rhinosinusitis; corticosteroid therapy; disease exacerbation; genomics; human; Letter; metabolic syndrome X; nose polyp; obesity; occupational asthma; patient compliance; patient education; priority journal; pulmonary rehabilitation; respiratory tract inflammation; RNA analysis; severe asthma; severe asthma; transcriptomics; asthma; disease management; disease predisposition; metabolism; severity of illness index, Asthma; Disease Management; Disease Susceptibility; Humans; Severity of Illness Index
